Probiotic-Mediated Modulation of the Gut Microbiome and Host Immunity for Sustainable Control of Antimicrobial Resistance

Abstract

ABSTRACT Antimicrobial resistance (AMR) represents one of the most critical threats to global public health, livestock sustainability, and ecological integrity. The relentless dissemination of multidrug-resistant (MDR) bacterial pathogens and antimicrobial resistance genes (ARGs) driven by indiscriminate antibiotic use requires immediate, non-antibiotic therapeutic alternatives. Probiotics— live beneficial microorganisms—have emerged as a targeted biological approach capable of modulating the intestinal microenvironment and bolstering host immune defenses. This comprehensive review synthesizes the multi-faceted mechanisms through which probiotic strains, primarily within the Lactobacillus, Bifidobacterium, and Bacillus genera, mitigate AMR. We evaluate competitive exclusion principles, bacteriocin production, short-chain fatty acid (SCFA)-mediated luminal acidification, and mucosal barrier reinforcement. Furthermore, we dissect the immunomodulatory cascades, specifically the activation of Toll-like receptors (TLR2/TLR4), enhancement of secretory IgA (sIgA) production, and regulation of T-regulatory (Treg) cell populations, which together promote pathogen clearance without exerting selective evolutionary pressure for resistance. Crucially, this review investigates the suppression of horizontal gene transfer (HGT) via plasmid conjugation inhibition and biofilm disruption. Quantitative benchmarking demonstrates that probiotic interventions achieve up to an 82% reduction in pathogenic enteric colonization and a 78% suppression of ARG conjugation rates in dysbiotic models. Addressing translational barriers—such as colonization resistance, strain-specific therapeutic variance, and regulatory standardization—this paper provides a strategic framework for deploying next-generation engineered probiotics and synbiotics as sustainable solutions against AMR. 

KEYWORDS: Antimicrobial Resistance; Gut Microbiome; Probiotics; Immunomodulation; Horizontal Gene Transfer; Short-Chain Fatty Acids; Dysbiosis; Mucosal Immunity.